RE:RE:RE:RE:RE:bad news, really bad newsDear Adam Peeler, Disclose!!!???? Are you kidding me? When did they disclose the move of the shares from the CEO to that numbered company (a DIFFERENT ENTITY?)???
Lemerson wrote:
Please stopping talking nonsense, 72mil is not related to the four generics. See below email The fee relates to products we looked at back in Q4 2015 and didn't pursue. As an aside, we'd have an obligation to continue to disclose the possibility of that payment. Pls see page s 9 in attached: In addition, pursuant to the AMCo Purchase Agreement, if the Corporation acquires certain specified pharmaceutical products from a specified third party introduced to the Corporation by certain of the Vendors within 12 months of the Acquisition Closing, the Corporation will pay to the Vendors an additional US$72 million. Adam Peeler VP, Investor Relations & Communications 277 Lakeshore Rd. E, Suite 302, Oakville, ON L6J 1H9 Tel : 9058425150 ext. 240 Fax : 905-842-5154 Email : adam.peeler@concordiarx.com Web : www.concordiarx.com NOTICE OF CONFIDENTIALITY This e-mail, including all materials contained in or attached to this e-mail, contains proprietary and confidential information solely for the internal use of the intended recipient. If you have received this email in error, please notify us immediately by return e-mail or otherwise and ensure that it is permanently deleted from your systems, and do not print, copy, distribute or read its contents.